ATLANTA, April 29, 2005 (PRIMEZONE) -- OTC Stock Review is adding the following stocks to the watch list this morning: Universal Detection Technology (OTCBB:UDTT), Martek Biosciences, Corp. (Nasdaq:MATK), LVMH Moet Hennessy Louis Vuitton (Pink Sheets:LVMHF) and Apple Computer (Nasdaq:AAPL).
Aggressive investors and traders should look at bio-terrorism detection device manufacturer Universal Detection Technology (OTCBB:UDTT) this morning. Yesterday, the company, the manufacturer of the BSM-2000 Anthrax Smoke Detector, issued a press release announcing that it has received a purchase order from Quantum Automation, UDTT's exclusive distributor in Singapore, Malaysia, and Thailand.
This could be good news for investors, as this purchase order marks the entry of Universal Detection Technologies in to not only the Pacific Rim, but the international market. The entry into the international market is particularly important, since industry sources estimate the global market for defense and security concerns is expected to grow from $28 billion in 2003 to over $170 billion in 2015.
Shares of Universal Detection Technology continue to trade around $0.20, just off of their 52-week low of $0.18. The BSM-2000 prototype was initially developed by NASA's Jet Propulsion Laboratory through the Technology Affiliates Program. As a result, UDTT holds the exclusive option on all intellectual property related to the development. In 2005, UDTT has been contracted to install an Anthrax Detector in the Miami International Airport and a major hotel.
For more in-depth coverage of Universal Detection Technology, visit http://www.otcstockreview.com and download the special report on Universal Detection Technology.
Other stocks of interest this morning are: Martek Biosciences, Corp. (Nasdaq:MATK) down 45.92 after warning that Q3 revenue would be lower than expected, LVMH Moet Hennessy Louis Vuitton (Pink Sheets:LVMHF) down 3.24%, and Apple Computer (Nasdaq:AAPL) down 1.14%.
After the Bell: OTCSR Watch List winner MicroStrategy (Nasdaq:MSTR) reported Q1 (Mar) earnings of $0.89 per share, $0.17 better than the Reuters Estimates consensus of $0.72; revenues rose 22.2% year/year to $60 million vs. the $61.8 million consensus.
If you have a public company with an exciting story to tell, contact us at info@otcstockreview.com.
OTCStockReview.com's email alert service is designed to notify investors of undervalued stocks, special situations, and long term growth opportunities. To subscribe to this free service, visit the OTC Stock Review home page at http://www.otcstockreview.com and select enter your email address in the "Receive E-Mail Alerts" field or send an email to newsletter@otcstockreview.com.
OTC Stock Review is not a Registered Investment Advisor or a Broker/Dealer. Furthermore, all information and/or opinions throughout this release are presented solely for informative purposes, and are not intended, nor should they be construed as investment advice. This release is a publication and service of OTC Stock Review, an independent research and investor-relations consulting firm that publishes investment-research reports and profiles on independently selected companies. Additionally, OTC Stock Review serves as a third party consultant to the Companies profiled on this website and receives fees either in cash, stock or a combination thereof, for the services it provides, including reimbursed expenses for preparation and distribution of materials included in this release. In this regard, please see below for specific amounts of compensation that OTC Stock Review received in profiling a specific company. Officers, directors, and employees of OTC Stock Review, may hold a long or short equity position of a profiled Company and may from time to time trade in these securities for their own accounts. The information available on this release is not an offer to buy or sell securities of the Companies profiled on this release. Information disclosed in this release is subject to change without notice. Information pertaining to each Company profiled in this release was provided to OTC Stock Review, by the Company and cannot be guaranteed by OTC Stock Review. Companies profiled herein, including those companies listed on the website's "Watch List" or "News List" section, carry a high investment risk; readers should carefully review the profiled Companies thoroughly with their investment advisor, stockbroker, or other such professional. Additionally, the "Watch List" and "News List" profiled on the website is not a "buy list" in that there will be no buy or sell recommendations issued by OTC Stock Review on companies profiled in any form. OTC Stock Review is not liable for any investment decisions by its readers or their advisors. Any analysis contained herein does not purport to be a complete analysis of the profiled Companies. Opinions stated are those of the indicated sources and not necessarily those of either OTC Stock Review or the Company being profiled in this release. Readers are encouraged to obtain copies of the profiled Company's periodic reports filed with United States Securities and Exchange Commission, which are generally available at http://www.sec.gov.
The purpose of this document is to introduce the reader to OTCStockReview.com and Universal Detection Technologies and contains public information about the Company. The document does not contain all the relevant material information necessary to evaluate the Companies profiled in this report and is not to be considered an offer to buy, sell, hold and/or otherwise trade in the securities of the companies profiled in this email. OTC Stock Review is compensated $5,000 a month from a third party who has an interest in Universal Detection Technologies and received 100,000 warrants at $.25 as additional compensation. OTC Stock Review is not compensated directly for this report. You can view our complete disclaimer at http://www.otcstockreview.com/disclaimer.htm
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCSR undertakes no obligation to update such statements.